4//SEC Filing
ONSI DOUGLAS E 4
Accession 0001104659-24-008417
CIK 0001509745other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 8:37 PM ET
Size
9.0 KB
Accession
0001104659-24-008417
Insider Transaction Report
Form 4
ONSI DOUGLAS E
DirectorCEO,CFO,Pres.,GC,Treas.&Sec.
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-01-26−7,500→ 0 total→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2024-01-26+7,500→ 73,646 total
Holdings
- 414,480(indirect: By HealthCare Ventures IX, L.P.)
Common Stock
Footnotes (4)
- [F1]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F2]The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.
- [F3]The reporting person is a Managing Director of HealthCare Partners IX, LLC which is the General Partner of HealthCare Partners IX, L.P., which is the General Partner of HealthCare Ventures IX, L.P. The reporting person beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein.
- [F4]On January 26, 2021, the reporting person was granted 7,500 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001270185
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 8:37 PM ET
- Size
- 9.0 KB